Folic acid use by women receiving routine gynecologic care

Obstetrics and Gynecology

Volumn 103, Issue 4, 2004, Pages 746-753

  Cleves, Mario A ^a   Hobbs, Charlotte A ^b   Collins, H Breck ^b   Andrews, Nancy ^b   Smith, Laura N ^b   Robbins, James M ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; ANTIANEMIC AGENT;

ACADEMIC ACHIEVEMENT; ADULT; AGE; ARTICLE; BIRTH DEFECT; DEMOGRAPHY; FEMALE; GYNECOLOGY; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; MARRIAGE; OUTPATIENT CARE; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIOECONOMICS; VITAMIN SUPPLEMENTATION; ADOLESCENT; ATTITUDE TO HEALTH; DIET SUPPLEMENTATION; HEALTH SERVICE; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; UTILIZATION REVIEW;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMATINICS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; WOMEN; WOMEN'S HEALTH SERVICES;

EID: 2342470812     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000117084.02395.a0     Document Type: Article

References (38)

1. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study: MRC Vitamin Study Research Group. Lancet 1991;338:131-7.
2. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981;282: 1509-11.
3. Use of folic acid for prevention of spina bifida and other neural tube defects: 1983-1991. MMWR Morb Mortal Wkly Rep 1991;40:513-6.
4. Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41:1-7.
5. March of Dimes and Gallup Organization. Folic acid and the prevention of birth defects: a national survey of pre-pregnancy awareness and behavior among women of childbearing age 1995-2002. Princeton (NJ): Gallup Organization; 2002. p. 1-65.
6. March of Dimes and Gallup Organization. Folic acid and the prevention of birth defects: a national survey among women of childbearing age 1995-2000. Princeton, (NJ): Gallup Organization; 2000. p. 1-56.
7. Power ML, Holzman GB, Schulkin J. Knowledge and clinical practice regarding folic acid among obstetrician-gynecologists. Obstet Gynecol 2000;95:895-8.
8. Marsack CR, Alsop CL, Kurinczuk JJ, Bower C. Pre-pregnancy counseling for the primary prevention of birth defects: rubella vaccination and folate intake [correction published in Med J Aust 1996;165:130]. Med J Aust 1995; 162:403-06.
9. Marsack CR, Alsop CL, Kurinczuk JJ, Bower C. Pre-pregnancy counseling for the primary prevention of birth defects: rubella vaccination and folate intake [correction published in Med J Aust 1996;165:130]. Med J Aust 1995; 162:403-06.
10. Pastuszak A, Bhatia D, Okotore B, Koren G. The effectiveness of pre-conceptional counseling on women's compliance with folic acid supplementation. In: Koren G, editor. Maternal fetal toxicity. 3rd ed. New York (NY): Marcel Dekker; 2001. p. 141-9.
11. de Weerd S, Thomas CM, Cikot RJ, Steegers-Theunissen RP, de Boo TM, Steegers EA. Preconception counseling improves folate status of women planning pregnancy. Obstet Gynecol 2002;99:45-50.
12. Sayers G, Scallan E, McDonnell R, Johnson Z. Knowledge and use of peri-conceptional folic acid among antenatal patients. Ir Med J 1997;90:236-8.
13. McDonnell R, Johnson Z, Doyle A, Sayers G. Folic acid knowledge and use among expectant mothers in 1997: a comparison with 1996. Ir Med J 1999;92:296-9.
14. Kloeblen AS, Batish SS. Understanding the intention to permanently follow a high folate diet among a sample of low-income pregnant women according to the Health Belief Model. Health Educ Res 1999;14:327-38.
15. Morin VI, Mondor M, Wilson RD. Knowledge on periconceptional use of folic acid in women of British Columbia. Fetal Diagn Ther 2001;16:111-5.
16. de Walle HE, Jong-van den Berg LT, Cornel MC. Periconceptional folic acid intake in the northern Netherlands. Lancet 1999;353:1187.
17. de Walle HE, de Jong-van den Berg LT. Insufficient folic acid intake in the Netherlands: what about the future? Teratology 2002;66:40-3.
18. Schader I, Corwin P. How many pregnant women in Christchurch are using folic acid supplements in early pregnancy? NZ Med J 1999;112:463-5.
19. Callender ES, Rickard R, Miller L, Rinsky-Eng J. Knowledge and use of folic acid supplementation: a study of Colorado women whose pregnancies were affected by a fetal neural tube defect. Clin Invest Med 2001;24:124-8.
20. Frishman GN, Spurrell TP, Heber WW. Folic acid: preconception knowledge and use by infertile women. J Reprod Med 2001;46:1025-30.
21. DiClemente CC, Prochaska JO, Fairhurst S, Velicer WF, Valesquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991; 59:295-304.
22. McDonnell R, Johnson Z, Doyle A, Sayers G. Determinants of folic acid knowledge and use among antenatal women. J Public Health Med 1999;21:145-9.
23. Morin P, De Wals P, Noiseux M, Niyonsenga T, St-Cyr-Tribble D, Tremblay C. Pregnancy planning and folic acid supplement use: results from a survey in Quebec. Prev Med 2002;35:143-9.
24. Morin P, De Wals P, St-Cyr-Tribble D, Niyonsenga T, Payette H. Pregnancy planning: a determinant of folic acid supplements use for the primary prevention of neural tube defects. Can J Public Health 2002;93:259-63.
25. Neimanis IM, Paterson JM, Bain E. Preventing neural tube defects: survey of preconceptional use of folic acid. Can Fam Physician 1999;45:1717-22.
26. Rosenberg KD, Gelow JM, Sandoval AP. Pregnancy intendedness and the use of periconceptional folic acid. Pediatrics 2003;111:1142-5.
27. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404-413.
28. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia (PA): Lippincott-Raven; 1998.
29. Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York (NY): John Wiley and Sons; 2001.
30. Sayers GM, Hughes N, Scallan E, Johnson Z. A survey of knowledge and use of folic acid among women of child-bearing age in Dublin. J Public Health Med 1997;19: 328-32.
31. Canfield MA, Anderson JL, Waller DK, Palmer SE, Kaye CI. Folic acid awareness and use among women with a history of a neural tube defect pregnancy: Texas, 2000-2001. MMWR Recomm Rep 2002;51:16-9.
32. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002;1-32.
33. Brown JE, Jacobs DR, Hartman TJ, Barosso GM, Stang JS, Gross MD, et al. Predictors of red cell folate level in women attempting pregnancy. JAMA 1997;277:548-52.
34. O'Rourke KM, Redlinger TE, Waller DK. Declining levels of erythrocyte folate during the postpartum period among Hispanic women living on the Texas-Mexico border. J Womens Health Gend Based Med 2000;9:397-403.
35. Burton A, Wilson S, Gillies AJ. Folic acid: Is self reported use of supplements accurate? J Epidemiol Community Health 2001;55:841-2.
36. Elkin AC, Higham J. Folic acid supplements are more effective than increased dietary folate intake in elevating serum folate levels. BJOG 2000;107:285-9.
37. Than LC, Watkins M, Daniel KL. Serum folate levels among women attending family planning clinics: Georgia, 2000. MMWR Recomm Rep 2002;51:4-8.
38. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. Minimum effective dose of folic acid for food fortification to prevent neural tube defects. Lancet 1997; 350:1666-9.